Product Description
Difluprednate ophthalmic is used to treat eye swelling and pain after eye surgery. Difluprednate ophthalmic is in a class of medications called corticosteroids. It works by stopping the release of certain natural substances that cause swelling and pain. (Sourced from: https://medlineplus.gov/druginfo/meds/a609025.html)
Mechanisms of Action: GR Agonist
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical,Ocular,Ophthalmic
FDA Designation: None *
Approval Status: Approved
Approved Countries: Bangladesh | Canada | Colombia | Dominican Republic | Ecuador | Egypt | France | India | Italy | Korea | Mexico | Peru | Turkey | United Arab Emirates | United States | Uruguay | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|